Seattle, Washington, United States The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Seattle.
The fund is constantly included in less than 2 investment rounds annually. The typical startup value when the investment from Integra Ventures is 50-100 millions dollars. The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2007. Comparing to the other companies, this Integra Ventures performs on 11 percentage points more the average number of lead investments. The real fund results show that this VC is 13 percentage points less often commits exit comparing to other companies. The increased amount of exits for fund were in 2014.
The current fund was established by Joseph Piper. The overall number of key employees were 3.
The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Integra Ventures, startups are often financed by Novo Holdings, JT International, JPMorgan Partners (JPMP). The meaningful sponsors for the fund in investment in the same round are Novo Holdings, Hambrecht & Quist Capital Management, Washington Research Foundation.. In the next rounds fund is usually obtained by Hambrecht & Quist Capital Management, Burrill & Company, WestRiver Group, LLC.
Among the most popular portfolio startups of the fund, we may highlight Raven Biotechnologies, Calypso Medical, Blue Heron Biotechnology. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Medical, Health Care.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Bank of Fukuoka | Fukuoka, Fukuoka Prefecture, Japan |
| BTS Investment Advisors | Switzerland, Zürich, Zurich |
| CARB-X | Boston, Massachusetts, United States |
| Cox Communications | Atlanta, Georgia, United States |
| Delin Ventures | England, London, United Kingdom |
| DFS Lab | Seattle, United States, Washington |
| DisrupTexas | - |
| En-Japan | Japan, Yamanashi, Yamanashi Prefecture |
| FIS | Florida, Jacksonville, United States |
| Globis | Chiyoda, Japan |
| Gould Investments | Great Neck, New York, United States |
| HNA Technic | China, Haikou, Hainan |
| Jukewang | China, Dongguang, Guangdong |
| Kruger Corporation | - |
| Norvestor Equity | Norway, Oslo |
| Phase 1 Ventures | - |
| WingsMedia | China, Shanghai |
| Xinyu Beiqing Jishi Investment Center | China, Jiangxi, Xinyu |
| XP Inc | Dallas, Texas, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
MediQuest Therapeutics | $23M | 16 Jun 2009 | Washington, United States | ||
Tepha | $10M | 06 Jun 2007 | Massachusetts, United States | ||
| $7M | 27 Mar 2007 | Portland, Oregon, United States | |||
Ampla Pharmaceuticals | $5M | 06 Dec 2006 | San Diego, California, United States | ||
MediQuest Therapeutics | $16M | 15 Jun 2006 | Washington, United States | ||
Corus Pharma | $40M | 07 Mar 2003 | Seattle, Washington, United States | ||
Raven Biotechnologies | $40M | 03 Jan 2003 | South San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
MediQuest Therapeutics | $23M | 16 Jun 2009 | Washington, United States | ||
Tepha | $10M | 06 Jun 2007 | Massachusetts, United States | ||
| $7M | 27 Mar 2007 | Portland, Oregon, United States | |||
Ampla Pharmaceuticals | $5M | 06 Dec 2006 | San Diego, California, United States | ||
MediQuest Therapeutics | $16M | 15 Jun 2006 | Washington, United States | ||
Corus Pharma | $40M | 07 Mar 2003 | Seattle, Washington, United States | ||
Raven Biotechnologies | $40M | 03 Jan 2003 | South San Francisco, California, United States |
